Literature DB >> 15533064

A quantitative study of epidermal Langerhans cells in cutaneous leishmaniasis caused by Leishmania tropica.

Simin Meymandi1, Shahriar Dabiri, Darya Dabiri, Richard I Crawford, Arsalan Kharazmi.   

Abstract

OBJECTIVE: The purpose of this study was to characterize the number and distribution of epidermal Langerhans cells in different clinical forms of dry-type cutaneous leishmaniasis (CL).
METHODS: Sixteen cases of dry-type cutaneous leishmaniasis caused by Leishmania tropica were studied. These cases were classified clinically as five cases of acute leishmaniasis with indurated papules, nodules and plaques with central crust formation and duration < 2 years, six cases of lupoid leishmaniasis with characteristic papules around previous scars of cutaneous leishmaniasis with duration > 2 years, and five cases of chronic nonlupoid type with nonhealing lesions of duration > 2 years. Paraffin-embedded blocks were stained with hematoxylin and eosin (H&E) and stained immunohistochemically for CD1a.
RESULTS: The number of Langerhans cells per millimeter length of epidermis was increased in acute cases compared to chronic and lupoid cases.
CONCLUSIONS: Lesions of acute leishmaniasis contain the greatest amounts of antigen for presentation, so Langerhans cells increase in number and in trafficking to present antigens derived from Leishman bodies to the cellular immune system. In chronic leishmaniasis, the Langerhans cell population is reduced, perhaps because of exhaustion of the source of Langerhans cells, or because of reduced response to modified antigen.

Entities:  

Mesh:

Year:  2004        PMID: 15533064     DOI: 10.1111/j.1365-4632.2004.02359.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  6 in total

1.  Immunopathological characterization of human cutaneous leishmaniasis lesions caused by Leishmania (Viannia) spp. in Amazonian Brazil.

Authors:  Cláudia Maria Castro Gomes; Maria Gloria Teixeira Sousa; Joyce Prieto Bezerra Menezes; Marliane Campos Batista; Ana Carolina Stocco Lima; Walter Belda; Daniel Bradshaw; Monica Elinor Alves Gama; Márcia Dalastra Laurenti; Fernando Tobias Silveira; Carlos Eduardo Pereira Corbett
Journal:  Parasitol Res       Date:  2017-02-21       Impact factor: 2.289

2.  Immunological perspectives of leishmaniasis.

Authors:  Susanne Nylén; Shalini Gautam
Journal:  J Glob Infect Dis       Date:  2010-05

Review 3.  A new view on cutaneous dendritic cell subsets in experimental leishmaniasis.

Authors:  Uwe Ritter; Anke Osterloh
Journal:  Med Microbiol Immunol       Date:  2006-06-20       Impact factor: 4.148

4.  Major risk factors and histopathological profile of treatment failure, relapse and chronic patients with anthroponotic cutaneous leishmaniasis: A prospective case-control study on treatment outcome and their medical importance.

Authors:  Mehdi Bamorovat; Iraj Sharifi; Shahriar Dabiri; Simin Shamsi Meymandi; Ali Karamoozian; Rezvan Amiri; Amireh Heshmatkhah; Mehdi Borhani Zarandi; Mohammad Reza Aflatoonian; Fatemeh Sharifi; Reza Kheirandish; Saeid Hassanzadeh
Journal:  PLoS Negl Trop Dis       Date:  2021-01-28

5.  Possible Interrelationship of Inflammatory Cells in Dry Type Cutaneous Leishmaniasis.

Authors:  Elham Taheri; Shahriar Dabiri; Manzumeh Shamsi Meymandi; Ebrahim Saedi
Journal:  Iran J Pathol       Date:  2017-04-01

6.  Evaluation of MDR1 and MRPA genes expression in different types of dry cutaneous leishmaniasis.

Authors:  Maryam Fekrisoofiabadi; Meisam Fekri; Alireza Moradabadi; Reza Vahidi; Morteza Khaleghi; Maryam Ram; Shahriar Dabiri
Journal:  BMC Res Notes       Date:  2019-12-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.